HIV
HIV preventative drug? CDC, February 2005

February 2005 Women's Health Update from the CDC/ATSDR
Q’s & A’s About Tenofovir HIV Prevention Trials Researchers believe that an HIV drug approved by the Food and Drug Administration - tenofovir disoproxil fumarate (tenofovir, brand name Viread) - taken daily as an oral preventive, is one of the most important new prevention approaches being investigated today. If proven safe and effective, this approach could help address the urgent need for a female-controlled prevention method for women worldwide who are unable, because of cultural and other barriers, to negotiate condom use. Furthermore, if effective, tenofovir, could provide an additional safety net for all men and women at risk due to sexual or drug-using behaviors, when combined with reducing the number of sexual partners, HIV counseling and testing, condom use, use of sterile syringes, and other prevention measures.
http://www.cdc.gov/hiv/pubs/faqs.htm#Tenofovir

© Speak Out Terms of use